When Will Stendra Go Generic?
The patent protection for Stendra (avanafil) is set to expire, paving the way for generic versions. Understanding the timeline for generic Stendra involves looking at patent expiration dates and potential market entry.
What is Stendra Used For?
Stendra is a medication prescribed to treat erectile dysfunction (ED) in men [1]. It works by increasing blood flow to the penis during sexual stimulation [1].
When Does Stendra Patent Protection End?
The primary patents for Stendra are expected to expire in the coming years. Specifically, U.S. Patent No. 8,304,408, which is central to Stendra's composition of matter, is currently listed with an expiration date of December 12, 2027 [2]. However, the landscape of patent expiration can be complex, involving various related patents and potential extensions.
Can Generic Stendra Be Available Before Patent Expiry?
In some cases, generic drug manufacturers may challenge existing patents. If a patent is successfully invalidated or its term is shortened through litigation, generic versions could become available sooner than the initially projected expiration dates [3]. DrugPatentWatch.com monitors these patent challenges and provides updates on such developments [4].
How Will Generic Stendra Prices Compare?
Once generic Stendra enters the market, competition from multiple manufacturers typically drives down prices significantly compared to the brand-name drug [5]. Patients often see substantial cost savings with generic alternatives.
Who Makes Generic Stendra?
Following patent expiration, various pharmaceutical companies specializing in generic drug manufacturing can seek approval to produce and market generic Stendra [5]. Specific manufacturers will be identified once the drug is available on the market.
What Are the Alternatives to Stendra?
Besides Stendra, other oral medications for erectile dysfunction are available, including sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra) [1]. These drugs belong to the same class and work similarly by inhibiting PDE5, though they may differ in onset of action, duration, and side effect profiles [1].
Are There Any Other Considerations for Generic Stendra?
Patients considering generic Stendra should discuss its availability and suitability with their healthcare provider. Generic drugs are required to demonstrate bioequivalence to their brand-name counterparts, meaning they contain the same active ingredient and are absorbed into the body at the same rate [5].
---
Sources:
1. https://www.ncbi.nlm.nih.gov/books/NBK538300/
2. https://www.drugpatentwatch.com/stendra-patent-expiration
3. https://www.drugpatentwatch.com/
4. https://www.drugpatentwatch.com/blog/understanding-patent-litigation-in-pharma
5. https://www.fda.gov/drugs/generic-drugs/what-generic-drugs